Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAAS blockade versus vitamin D supplementation in secondary hyperparathyroidism
2014-003645-10Phase 4Completed
- Sponsor
- Department of Endocrinology and Internal Medicine
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vitamin d in secondary hyperparathyroidism (SHPT) and Vitamin D deficiency (VDD) (2 arms), sponsored by Department of Endocrinology and Internal Medicine. Started Oct 2014; status: completed.
02
Drugs
vitamin d
03
Conditions
secondary hyperparathyroidism (SHPT)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2014-003645-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003645-10.